UBS Group
NFH

UBS Group’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

UBS Group’s Portfolio NFH Stock Details NFH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,657
Closed -$203K – 11578
2021
Q4 		$203K Buy
17,657
+2,105
+14% +$23.7K ﹤0.01% 5676
2021
Q3 		$175K Buy
15,552
+14,934
+2,417% +$166K ﹤0.01% 5422
2021
Q2 		$7K Sell
618
-815
-57% -$9.14K ﹤0.01% 8403
2021
Q1 		$16K Buy
1,433
+1,326
+1,239% +$13.5K ﹤0.01% 7604
2020
Q4 		$1K Sell
107
-1,388
-93% -$12K ﹤0.01% 8307
2020
Q3 		$11K Buy
1,495
+1,098
+277% +$9.01K ﹤0.01% 6813
2020
Q2 		$3K Sell
397
-663
-63% -$5.38K ﹤0.01% 7580
2020
Q1 		$9K Sell
1,060
-1,009
-49% -$9.17K ﹤0.01% 7037
2019
Q4 		$21K Buy
+2,069
New +$21.1K ﹤0.01% 6858

Other funds holding NFH

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

UBS Group's NFH Position: Q1 2022 in Review

UBS Group sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 17,657 shares — an estimated $203K sold.

UBS Group first reported a position in NFH in Q4 2019 and held it in 9 quarters. The position peaked at $203K in Q4 2021. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

  • UBS Group reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • UBS Group sold 17,657 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $203K.
  • UBS Group first reported a position in New Frontier Health Corporation Ordinary Shares in Q4 2019 and held it in 9 quarters.
  • UBS Group's New Frontier Health Corporation Ordinary Shares position peaked at $203K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.